HDFC Securities' research report on UltraTech Cement
UTCEM delivered yet another stellar quarter, as its 3QFY21 consolidated net sales/EBITDA/APAT soared 17/47/98% YoY to Rs 122.5/30.9/15.8bn respectively. It is driven by a robust 14% volume growth (2x industry growth) and superior opex controls (down 4% YoY). Healthy realisation also boosted the gains. The company further lowered its working capital, reducing net debt/EBITDA to 0.9x (vs 1.8x in Mar’20). We continue to like UTCEM for its strong volume focus along with superior margin delivery and working capital controls.
Outlook
We maintain BUY with a higher target price of Rs 6,720/share (16x Dec’22E consolidated EBITDA).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.